ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

COVID-19: Another Hong Kong citizen dies after receiving Chinese vaccine shot

Hong Kong, April 4 (ANI): The chronically ill 62-year-old man in Hong Kong died after receiving Chinese vaccine Sinovac shots last month, the country's health authorities revealed on Sunday.

ANI Apr 04, 2021 21:27 IST googleads

Representative image

Hong Kong, April 4 (ANI): The chronically ill 62-year-old man in Hong Kong died after receiving Chinese vaccine Sinovac shots last month, the country's health authorities revealed on Sunday.
The news came as Hong Kong Chief Secretary Matthew Cheung Kin-chung, urged the public to stay vigilant over the five-day holiday break, which this year encompasses the Ching Ming Festival - also known as tomb-sweeping day - in which Chinese families visit cemeteries to commemorate their ancestors, South China Morning Post (SCMP) reported.
The man died on Friday after receiving the vaccine last month.
He was diagnosed with high blood pressure at a general outpatient clinic on Thursday and experienced difficulty breathing on the street on Friday morning. When an ambulance arrived, he was found to have suffered a cardiac arrest and sent to Pok Oi Hospital, where he was certified dead.
He was the 14th person to have died after getting shot of a jab since the city launched its COVID-19 vaccination drive in late February. However, no link between the deaths and the vaccines has been established so far, reported SCMP.
About 68,900 people, or 0.9 per cent of the population in Hong Kong, have already received the second dose of China-made Sinovac.
Hong Kong recorded 11,508 total confirmed cases of COVID-19, while the death toll in the country stands at 205. (ANI)

Get the App

What to Read Next

Asia

India consistently supported Maldives in crisis: Mohamed Nasheed

India consistently supported Maldives in crisis: Mohamed Nasheed

He highlighted India's role as a "first responder" for the Maldives, emphasising that India's support during critical periods has been fundamental to the stability and security of the island nation.

Read More
Europe

Akshar Foundation highlights Northeast India’s development at UN

Akshar Foundation highlights Northeast India’s development at UN

On the sidelines of the 61st session of the United Nations Human Rights Council (UNHRC), Mazin Mukhtar, Co-founder and Associate Director of the Akshar Foundation, highlighted development initiatives in India's northeastern region and urged global recognition of progress made in previously neglected areas.

Read More
Asia

China’s expanding system of censorship exposed in Dharamshala

China’s expanding system of censorship exposed in Dharamshala

The event titled "Understanding China's System of Political Repression: Voices of Resistance through Art and Journalism" brought together prominent voices critical of China's information control, as reported by Phayul.

Read More
Asia

MEA rejects Pakistan’s statement on India-Canada deal

MEA rejects Pakistan’s statement on India-Canada deal

"We reject this statement made by Pakistan on the matter. India's credentials regarding non-proliferation are impeccable and well recognised by the global community. A country with a well-documented history of clandestine nuclear proliferation can hardly preach the virtues of export controls and proliferation risks. Such ludicrous statements are nothing more than an attempt by Pakistan to distract from its own abysmal record," he said.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.